Funding
$200.0M
Models
1
Overview
Synchron is a brain-computer interface (BCI) company developing the Stentrode, a stentrode-based BCI implant that does not require open-brain surgery. Founded by neurologist Tom Oxley, the company has raised over $345M in total funding including a $200M Series D in 2024. Synchron's COMMAND and SWITCH clinical trials demonstrated no serious device-related adverse events across 6 patients, and the FDA has approved the Stentrode for early feasibility studies. The company is based in New York with origins in Melbourne, Australia.
Verified record
- Verified deployments
- None on file
- Active incidents
- None on file
DEPLOY Intelligence
Market intelligence for physical AI
Analyst-grade signals, competitive tracking, and investment context across the global physical AI landscape. Launching 2026.
Key facts
CEO
Total funding
Product
Clinical trials
Safety
Target
Data & sources
Web sources
1
1 source backing this record.View all →
Models (1)
View all models →Current leadership (1)
- Tom Oxley Founder & CEOreported, not verified
Founders (1)
- Tom Oxleycofounder
Safety record
No incidents on record for Synchron.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Recent coverage
Synchron in third-party press
Peer companies
- Xiaomi3 models
- Baidu2 models
- Brilliant Labs2 models
- Even Realities2 models
- Hark2 models
- Open Bionics2 models
Financial state
- Reporting basis
- private_reported
- Lifecycle stage
- growth
- Counterparty risk class
- moderate
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Funding rounds (1)
- Series D2024-12-01
$200M(reported)
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJul 6, 2026
Added to the verified registry
Sources (1)
Common questions
- What is Synchron?
- Synchron is a brain-computer interface (BCI) company developing the Stentrode, a stentrode-based BCI implant that does not require open-brain surgery. Founded by neurologist Tom Oxley, the company has raised over $345M in total funding including a $200M Series D in 2024. Synchron's COMMAND and SWITCH clinical trials demonstrated no serious device-related adverse events across 6 patients, and the FDA has approved the Stentrode for early feasibility studies. The company is based in New York with origins in Melbourne, Australia.
- What does Synchron make?
- Synchron has 1 robot model on the DEPLOY registry: Synchron Stentrode (Synchron builds physical robots).
- Who competes with Synchron?
- On the DEPLOY registry, peer companies to Synchron building in the same form factors include Xiaomi, Baidu, Brilliant Labs, Even Realities.
- Who is the CEO of Synchron?
- Tom Oxley is the ceo of Synchron, per the DEPLOY registry.
- Where is Synchron headquartered?
- Synchron is headquartered in New York, NY, USA.
- How much funding has Synchron raised?
- Synchron has raised approximately $200M in disclosed funding on record in the DEPLOY registry.
- Where does Synchron operate robots?
- Synchron is a robot manufacturer and does not directly operate deployments on the DEPLOY registry. Its products are deployed by customer operators; see the company page for the verified deployment record.
- Is Synchron a top robotics company?
- On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, Synchron ranks in roughly the top 15% of companies tracked by the registry.
- When was Synchron founded?
- Synchron was founded in 2016.
- Is Synchron safe?
- Synchron has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 1 source (no primary) · last reviewed 2026-07-06
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-07-06
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Synchron.Peer companies
- Xiaomi3 models
- Baidu2 models
- Brilliant Labs2 models
- Even Realities2 models
- Hark2 models
- Open Bionics2 models
In the press
Recent coverage mentioning Synchron from third-party publications. Automatically surfaced; not part of the verified registry record.
Synchronizing the future of aerospace structural integrity
Autonomous Structural Health Monitor Sensors offer engineers a way to cope with the deluge of data Continue reading Synchronizing the future of aerospace structural integrity at…
AI Computing Reaches for Space: Nayuta Space Targets Orbital Data Center Constellation
China's Nayuta Space unveils Alaya orbital computing constellation, planning 12,500 AI compute satellites in sun-synchronous orbit with aerodynamic rocket recovery.
Where to watch drone shows this Independence Day weekend
If your Fourth of July plans include gazing up at the night sky, you have more options than ever this year. While fireworks remain the centerpiece of many Independence Day…
Brain-computer interface based on Rice research wins FDA approval for first clinical trial
A brain-computer interface based on Rice University research won FDA approval for its first clinical trial, advancing BCI technology for patients with paralysis or amputation.
Synchron raises $200M Series D to support BCI commercialization
Synchron raised $200M in Series D financing to support commercialization of its Stentrode brain-computer interface, bringing total funding to over $345M and pushing BCI investment…
Synchron's Brain-Computer Interface Evaluated in COMMAND Early Feasibility Study
Synchron's COMMAND study showed reliable performance of the Stentrode BCI implant with no serious adverse events related to the brain or vasculature during the 12-month period…
Machine-readable surfaces
- Markdown mirror: /companies/synchron.md
- RSS feed: /companies/synchron/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/ac5afad9-cfd5-4b66-aa18-4d3aacf16560
- Revision history: /companies/synchron/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Xiaomi3 models
- Baidu2 models
- Brilliant Labs2 models
- Even Realities2 models
- Hark2 models
- Open Bionics2 models
Video
Hello, world! Meet Rodney - one of our heroes. Living with ALS, he's redefining independence using the Synchron brain-computer interface (BCI) + NVIDIA Holoscan + Apple Vision Pro to control his digital devices. In thi
A group of humanoid robots showed off their synchronized Kung Fu moves at China’s Spring Festival Gala. See the stunning tech performance.
Cobot, track and manipulator move in perfect sync. Delivering smooth, precise welds even on complex workpieces with the WeCobot ONE welding software. ⚙️ Practi
What other uses for BCI would you like to see? Share them in the comments. Elon Musk should start working on improving Neuralink to keep up with Synchron. Syn
Hello everyone, today we look at a company called Synchron. They are the first ones ever to connect a Brain Computer Interface (BCI) to an Apple Vision Pro. Nex
Synchron's lab automation intelligence makes it possible to create automation processes for every type of laboratory. By integrating smart robot solutions we ma
Synchron's lab automation intelligence makes it possible to create automation processes for every type of laboratory. By integrating smart robot solutions we ma
Synchron's lab automation intelligence makes it possible to create automation processes for every type of laboratory. By integrating smart robot solutions we ma
Synchron's lab automation intelligence makes it possible to create automation processes for every type of laboratory. By integrating smart robot solutions we ma
Thank you for visiting us at our booth during Lab Automation 2022. Hope you have enjoyed the experience! We sure did! Synchron's lab automation intelligence m
Synchron's lab automation intelligence makes it possible to create automation processes for every type of laboratory. By integrating smart robot solutions we ma
Synchron's lab automation intelligence makes it possible to create automation processes for every type of laboratory. By integrating smart robot solutions we ma
Synchron's lab automation intelligence makes it possible to create automation processes for every type of laboratory. By integrating smart robot solutions we ma
Dive into the defining debate shaping the future of medical neurotechnology by comparing the two leading brain-computer interface (BCI) platforms: Neuralink and
Reality vs attention
Synchron draws attention at the 73rd percentile but verifies reality at the insufficient-data level among wearable robots.
6-month trend
Analysis
Broad public reach with 1.2M video views.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Jul 19, 2026